PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0740394|hyperuricemia |
| Sentences | 23 |
| PubMedID- 24472219 | It is also significant in that its simultaneous analyses revealed that hyperuricemia is significantly associated with metabolic syndrome and that low levels of blood lead can affect hyperuricemia. |
| PubMedID- 26064845 | hyperuricemia has attributed to hyperinsulinemia in metabolic syndrome and decreased excretion of uric acid causing endothelial dysfunction in kidney leads to renal disease and cardiovascular disorders. |
| PubMedID- 22618644 | hyperuricemia in children with post-diarrheal hemolytic uremic syndrome. |
| PubMedID- 24527421 | hyperuricemia is associated with metabolic syndrome as well as gout, and the prevalence of hyperuricemia is increasing in korea. |
| PubMedID- 22615932 | There is evidence that hyperuricemia is associated with the metabolic syndrome [1], [2] and incident type 2 diabetes [3], [4]. |
| PubMedID- 25582475 | Conclusion: hyperuricemia in children with primary nephrotic syndrome correlated with the increase of serum creatinine, urea and blood uric acid/creatinine ratio, the decrease of creatinine clearance rate and the occurance of hypertension. |
| PubMedID- 22095983 | Objective: hyperuricemia is common in patients with metabolic syndrome. |
| PubMedID- 26425051 | Additionally, hyperuricemia associates directly with hypertension, metabolic syndrome, chronic kidney disease, and peripheral vascular disease (7). |
| PubMedID- 23966810 | We evaluated the combination effect of the alkalizer citrate with the xanthine oxidase inhibitor allopurinol on renal function and uric acid in patients with hyperuricemia associated with obesity and/or metabolic syndrome (mets), who were extracted from among the subjects enrolled in a prospective randomized controlled study aimed at assessing the efficacy of such a combination for improving renal function. |
| PubMedID- 21346177 | Objective: hyperuricemia is strongly associated with obesity and metabolic syndrome and can predict visceral obesity and insulin resistance. |
| PubMedID- 26141680 | Objectives: to investigate the influence of mets (metabolic syndrome) in combination with hyperuricemia on left ventricular hypertrophy (lvh) in residents in the rural area of northeast china. |
| PubMedID- 22723994 | Similarly, rats administered uricase inhibitors to induce hyperuricemia, developed features of the metabolic syndrome [17]. |
| PubMedID- 20158446 | Background: hyperuricemia is associated with metabolic syndrome and has emerged as a marker for both type 2 diabetes and cardiovascular disease. |
| PubMedID- 22701608 | Additionally, hyperuricemia has been associated with metabolic syndrome and implicated as a risk factor in the etiology of hypertension, atherosclerosis, insulin resistance and diabetes [3], [4]. |
| PubMedID- 23588856 | hyperuricemia has been attributed to hyperinsulinemia in metabolic syndrome and to decreased uric acid excretion in kidney dysfunction, and is not acknowledged as a main mediator of metabolic syndrome, renal disease, and cardiovascular disorder development. |
| PubMedID- 26208103 | As previous reports [37, 38], obesity and metabolic syndrome are strongly associated with hyperuricemia likely as a consequence of insulin resistance, which explains larger bmi and higher tg level could elevate ua level. |
| PubMedID- 21694941 | The close association of hyperuricemia with metabolic syndrome, hypertension and renal insufficiency ensures that nephrologists will see increasing numbers of gout-afflicted patients. |
| PubMedID- 22712045 | Our results suggest that individuals with high normal uric acid levels or asymptomatic hyperuricemia are at risk of metabolic syndrome. |
| PubMedID- 25356596 | In addition to the morbidity that is attributable to gout, hyperuricemia is also associated with metabolic syndrome, hypertension, and cardiovascular disease. |
| PubMedID- 22393348 | Additionally, insulin resistance, abdominal obesity, dyslipidemia, arterial hypertension, diabetes, and the metabolic syndrome are highly associated with hyperuricemia and gout [3], [4]. |
| PubMedID- 22011411 | hyperuricemia is present in patients with the metabolic syndrome (2) and in subjects with insulin resistance (3). |
| PubMedID- 26004548 | Conclusions: it can be concluded that hyperuricemia is strongly associated with metabolic syndrome. |
| PubMedID- 23804456 | High uricemia in humans may protect against oxidative stress, but hyperuricemia also associates with the metabolic syndrome, and urate and uric acid can crystallize to cause gout and renal dysfunctions. |
Page: 1